US Patent Issued to Novo Nordisk on Aug. 26 for "Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid" (Danish Inventors)

ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,396,953, issued on Aug. 26, was assigned to Novo Nordisk A/S (Bagsvaerd, Denmark).

"Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid" was invented by Betty Lomstein Pedersen (Glostrup, Denmark) and Birgitte Nissen (Ballerup, Denmark).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to pharmaceutical compositions comprising a peptide, such as a GLP-1 peptide and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid. The invention further relates to processes for the preparation of such compositions, and their use in medicine."

The patent was filed on Nov. 3, 2023, under Application ...